Thomas Cusick Insider Trading for 8,343 Shares of Columbia Sportswear Company (COLM); Contrafect (CFRX) Shorts Raised By 10.16%

Columbia Sportswear Company (NASDAQ:COLM) Logo

Contrafect Corporation (NASDAQ:CFRX) had an increase of 10.16% in short interest. CFRX’s SI was 183,300 shares in April as released by FINRA. Its up 10.16% from 166,400 shares previously. With 196,400 avg volume, 1 days are for Contrafect Corporation (NASDAQ:CFRX)’s short sellers to cover CFRX’s short positions. The SI to Contrafect Corporation’s float is 0.37%. The stock decreased 1.85% or $0.03 during the last trading session, reaching $1.59. About 41,158 shares traded. ContraFect Corporation (NASDAQ:CFRX) has declined 21.95% since April 14, 2017 and is downtrending. It has underperformed by 33.50% the S&P500.

ContraFect Corporation (NASDAQ:CFRX) Ratings Coverage

Among 3 analysts covering ContraFect (NASDAQ:CFRX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. ContraFect had 5 analyst reports since December 31, 2015 according to SRatingsIntel. William Blair initiated the shares of CFRX in report on Wednesday, September 28 with “Outperform” rating. Maxim Group maintained the stock with “Buy” rating in Thursday, December 31 report. Roth Capital downgraded the stock to “Neutral” rating in Tuesday, May 10 report. Maxim Group downgraded ContraFect Corporation (NASDAQ:CFRX) on Friday, July 22 to “Buy” rating.

ContraFect Corporation, a clinical-stage biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases in the United States. The company has market cap of $117.11 million. The Company’s lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; and CF-404, a combination of human monoclonal antibodies for the treatment of life-threatening seasonal and pandemic varieties of human influenza. It currently has negative earnings. The firm has a collaboration research agreement with The Rockefeller University to identify new lysin therapeutic candidates targeting Gram-negative bacteria; and license agreement with Trellis Bioscience LLC for mAbs in the field of influenza.

The Columbia Sportswear Co’s EVP & COO, Thomas Cusick, the well informed person made a sale of – 8,343 Columbia Sportswear Co’s shares, calculated based on the stock price per share of $82.5 for each one share. The unloaded insider shares had a value of approximately $688,298 U.S Dollars. Currently, Thomas Cusick owns 44,263 shares or roughly 0.06% of the Company’s total market cap (Market Capitalization is a measurement of business value based on share price and number of shares outstanding). The transaction was dated April 13, 2018 and was revealed in a Form 4 filed with the SEC. The Form 4 is obtainable online here.

Columbia Sportswear Company designs, sources, markets, and distributes outdoor and active lifestyle apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. The company has market cap of $5.59 billion. The firm provides apparel, accessories, and equipment for men, women, and youth under the Columbia, Mountain Hardwear, Sorel, and prAna brands. It has a 53.58 P/E ratio. The Company’s products are used during various outdoor activities, such as skiing, snowboarding, hiking, climbing, mountaineering, camping, hunting, fishing, trail running, water sports, and adventure travel.

The stock decreased 1.14% or $0.92 during the last trading session, reaching $79.84. About 231,444 shares traded. Columbia Sportswear Company (NASDAQ:COLM) has risen 31.21% since April 14, 2017 and is uptrending. It has outperformed by 19.66% the S&P500.

Analysts await Columbia Sportswear Company (NASDAQ:COLM) to report earnings on April, 26. They expect $0.58 earnings per share, up 13.73% or $0.07 from last year’s $0.51 per share. COLM’s profit will be $40.61 million for 34.41 P/E if the $0.58 EPS becomes a reality. After $1.31 actual earnings per share reported by Columbia Sportswear Company for the previous quarter, Wall Street now forecasts -55.73% negative EPS growth.

Investors sentiment increased to 1.39 in 2017 Q4. Its up 0.19, from 1.2 in 2017Q3. It is positive, as 19 investors sold Columbia Sportswear Company shares while 47 reduced holdings. 37 funds opened positions while 55 raised stakes. 26.27 million shares or 1.51% less from 26.67 million shares in 2017Q3 were reported. Fny Managed Accounts Ltd Co stated it has 24 shares or 0% of all its holdings. Loomis Sayles & Lp stated it has 451,632 shares or 0.07% of all its holdings. Ahl Llp stated it has 0.17% in Columbia Sportswear Company (NASDAQ:COLM). Zebra Limited Liability Co holds 0.61% or 25,025 shares. Parametric Assoc Lc reported 102,010 shares. Wellington Management Gp Llp has 227,292 shares. Pitcairn Com has 3,262 shares. Pacad Investment Limited reported 1,700 shares. Alliancebernstein Lp reported 0% stake. Moreover, Us Savings Bank De has 0% invested in Columbia Sportswear Company (NASDAQ:COLM). Farmers Merchants Investments holds 0% of its portfolio in Columbia Sportswear Company (NASDAQ:COLM) for 114 shares. Stone Ridge Asset Mgmt Limited Company owns 26,854 shares for 0.13% of their portfolio. Stifel Fincl holds 3,642 shares. 250 were reported by Qci Asset Mngmt Inc New York. Oppenheimer Asset Mgmt reported 3,984 shares or 0.01% of all its holdings.

Since February 12, 2018, it had 0 insider purchases, and 8 selling transactions for $9.48 million activity. 11,694 shares were sold by KLENZ WALTER, worth $887,224. 6,628 Columbia Sportswear Company (NASDAQ:COLM) shares with value of $510,356 were sold by ALBERS MURREY R. 11,608 Columbia Sportswear Company (NASDAQ:COLM) shares with value of $888,244 were sold by GEORGE EDWARD S. Shares for $675,118 were sold by Fogliato Franco. Another trade for 16,006 shares valued at $1.26 million was sold by Cusick Thomas B. Bragdon Peter J also sold $2.57 million worth of Columbia Sportswear Company (NASDAQ:COLM) on Tuesday, March 6. BANY SARAH had sold 11,846 shares worth $879,482.

Columbia Sportswear Company (NASDAQ:COLM) Institutional Positions Chart